All stock lists
UNITED THERAPEUTICS Corp (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
Healthcare · Drug Manufacturers - Specialty & Generic
589.92+2.42 (+0.41%)
Insider Score
––Not scored
UTHR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Congress Trading
Recent trades of UTHR by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Michael T. McCaulHouse / R | Sale$100.00K – $250.00K | May 12, 2023 |
| Michael T. McCaulHouse / R | Sale$15.00K – $50.00K | May 12, 2023 |
| Michael T. McCaulHouse / R | Purchase$15.00K – $50.00K | Mar 1, 2022 |
| Michael T. McCaulHouse / R | Purchase$1.00K – $15.00K | Mar 1, 2022 |
| Michael T. McCaulHouse / R | Sale$15.00K – $50.00K | Jan 28, 2022 |
| Michael T. McCaulHouse / R | Sale$1.00K – $15.00K | Jan 28, 2022 |
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
UTHR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New UTHR patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to UTHR from public contracts
Source: USAspending.gov
Recently reported changes in UTHR holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing UTHR, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| House | Sell | $100.00K – $250.00K | May 12, 2023 | |
| House | Sell | $15.00K – $50.00K | May 12, 2023 | |
| House | Buy | $15.00K – $50.00K | Mar 1, 2022 | |
| House | Buy | $1.00K – $15.00K | Mar 1, 2022 | |
| House | Sell | $15.00K – $50.00K | Jan 28, 2022 | |
| House | Sell | $1.00K – $15.00K | Jan 28, 2022 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.